Georgette D Kanmogne
Overview
Explore the profile of Georgette D Kanmogne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Annadurai N, Kanmogne G
Cells
. 2024 Sep;
13(17.
PMID: 39272987
Blood-brain barrier (BBB) injury and dysfunction following infection with the human immunodeficiency virus (HIV) enables viral entry into the brain, infection of resident brain cells, neuronal injury and subsequent neurodegeneration...
2.
Kanmogne G
Cells
. 2024 Apr;
13(8.
PMID: 38667287
Endothelial cell activation, injury, and dysfunction underlies the pathophysiology of vascular diseases and infections associated with vascular dysfunction, including human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome. Despite viral suppression...
3.
Bhargavan B, Kanmogne G
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628764
COVID-19 progression often involves severe lung injury, inflammation, coagulopathy, and leukocyte infiltration into pulmonary tissues. The pathogenesis of these complications is unknown. Because vascular endothelium and neutrophils express angiotensin-converting enzyme-2...
4.
Bhargavan B, Kanmogne G
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142345
In SARS-CoV-2-infected humans, disease progression is often associated with acute respiratory distress syndrome involving severe lung injury, coagulopathy, and thrombosis of the alveolar capillaries. The pathogenesis of these pulmonary complications...
5.
Bhargavan B, Woollard S, McMillan J, Kanmogne G
Mol Neurodegener
. 2021 Nov;
16(1):78.
PMID: 34809709
Background: Neurocognitive impairment is present in 50% of HIV-infected individuals and is often associated with Alzheimer's Disease (AD)-like brain pathologies, including increased amyloid-beta (Aβ) and Tau hyperphosphorylation. Here, we aimed...
6.
Kanmogne G, Fonsah J, Umlauf A, Moul J, Doh R, Kengne A, et al.
Sci Rep
. 2020 Aug;
10(1):14016.
PMID: 32820234
HIV-associated neurocognitive deficits include impaired speed-of-information processing (SIP) and motor functions. There is lack of Cameroonian adult norms for assessing SIP or motor functions. This study of 683 Cameroonians (320...
7.
Acharya A, Tagny C, Mbanya D, Fonsah J, Nchindap E, Kenmogne L, et al.
Int J Mol Sci
. 2020 Feb;
21(5).
PMID: 32106437
Integrase strand-transfer inhibitors (INSTIs) are now included in preferred first-line antiretroviral therapy (ART) for HIV-infected adults. Studies of Western clade-B HIV-1 show increased resistance to INSTIs following mutations in integrase...
8.
Kanmogne G, Fonsah J, Umlauf A, Moul J, Doh R, Kengne A, et al.
J Int Neuropsychol Soc
. 2020 Feb;
26(6):607-623.
PMID: 32066518
Objective: There is lack of Cameroonian adult neuropsychological (NP) norms, limited knowledge concerning HIV-associated neurocognitive disorders in Sub-Saharan Africa, and evidence of differential inflammation and disease progression based on viral...
9.
Bhargavan B, Kanmogne G
Sci Rep
. 2019 Jul;
9(1):10689.
PMID: 31337802
HIV subtypes distribution varies by geographic regions; this is likely associated with differences in viral fitness but the predictors and underlying mechanisms are unknown. Using in-vitro, in-vivo, and ex-vivo approaches,...
10.
Acharya A, Fonsah J, Mbanya D, Njamnshi A, Kanmogne G
AIDS Res Hum Retroviruses
. 2019 Mar;
35(8):762-768.
PMID: 30860392
Variations in the HIV genome influence HIV/AIDS epidemiology. We report here a novel HIV-1 unique recombinant form (URF) isolated from an HIV-infected female (NACMR092) in Cameroon, based on the analyses...